Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A

Several plasma-derived intermediate and high-purity concentrates containing von Willebrand factor (VWF) and factor VIII (FVIII) are currently available. The main role of these products in the management of the pediatric population is represented by the replacement therapy in patients with severe or...

Descripción completa

Detalles Bibliográficos
Autores principales: Castaman, Giancarlo, Linari, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936816/
https://www.ncbi.nlm.nih.gov/pubmed/27445481
http://dx.doi.org/10.2147/TCRM.S87543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936816/
https://www.ncbi.nlm.nih.gov/pubmed/27445481
http://dx.doi.org/10.2147/TCRM.S87543

Ejemplares similares